PubMed Health⌕ Search

Biomedical subjects

P G Hugenholtz

Publications and source records attributed to P G Hugenholtz.

At least 19 recordsLinked to original sources
PubMed1992

Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.

Nicorandil is a potent coronary vasodilator. To assess its long-term antianginal effect, we designed a randomized, parallel double-blind trial of 6 weeks' duration comparing nicorandil (10 or 20 mg b.i.d.) with propranolol (40 or 80 mg t.i.d.). The study comprised 77 men with stable angina, no maintenance medication at entry, and an exercise test positive for angina and ST-segment depression. The therapy was started with 10 mg nicorandil b.i.d. or 40 mg propranolol t.i.d. After 3 weeks, the dosage could be doubled according to clinical criteria. Four men receiving nicorandil and one receiving propranolol were withdrawn with side effects; in three cases, the data were not complete. Thus, comparative data were obtained in 69 patients; in 51 of these (26 receiving nicorandil and 25 receiving propranolol), the dosage was increased to the higher level. Blood pressure and heart rate were unaltered by nicorandil and lowered by propranolol. The number of anginal attacks decreased relative to baseline on nicorandil and propranolol (p < 0.002), but total exercise duration was not influenced by either drug. The exercise test performed 2 h after either pill ingestion showed a decrease and a delay in occurrence of myocardial ischemia. The test performed 12 h after medication exhibited reduced ischemia, whereas only propranolol resulted in delayed ST-segment depression. The double product of heart rate and systolic blood pressure was affected only slightly by nicorandil and reduced significantly by propranolol (p < 0.001). Thus, nicorandil medication affords similar improvement as propranolol in patients with angina pectoris, but the mode of action appears to be different.

Angina Pectoris↗
PubMed1979

[Regional myocardial shortening and blood flow through the graft after aorto-coronary bypass surgery].

In 56 patients operated on for coronary artery bypass grafting the relation between regional epicardial shortening, bypass flow, reactive hyperemia, and time postoperative was determined. Regional shortening in the newly perfused region was measured by a new technique employing four to six radiopaque markers sutured in pairs to the epicardium juxtaposed by 2 cm, and from 0 to 3 cm distal to the coronary anastomosis. Marker pairs were filmed sequentially at each follow up. Excluding dyskinesia, shortening fraction (ratio of shortening to maximum marker separation) for all graft regions at 1 week was 9.8 p. 100, 1 month 12.8 p. 100, 3 months 13.3 p. 100, and 6 months 13.9 p. 100. Average graft flow was 56 ml/mn and average reactive hyperemia was 25 p. 100 with 37 p. 100 of grafts having no response. There was a positive correlation between shortening fraction and flow, becoming significant (null hypothesis: r = 0) when reactive hyperemia exceeded 20 p. 100. Correlation was greatest at 1 week and 1 month, but became non-significant at 6 months implicating other factors such as new collateral development, bypass closure, new infarction, or altered medical therapy. It appears that bypass flow and reactive hyperemia do have a certain predictive value as to regional shortening up to 1 to 3 months postoperative.

Adult↗
PubMed1979

Intra-aortic balloon pumping in coronary artery disease.

Cardiogenic shock and severe left ventricular failure after acute myocardial infarction, refractory angina pectoris at rest either of new onset or superimposed on stable angina pectoris, or occurring in the post infarct (less than 2 weeks) period, and the suspicion of a slowly evolving infarction are the main indications for intra-aortic balloon pumping at the Thoraxcenter. 76 patients were treated with intra-aortic balloon pumping for cardiogenic shock after acute myocardial infarction and left ventricular failure, 42/76 (55%) could be weaned, 9 (12%) died within 3 months, 33 (43%) survived over 3 months, to date 29 are alive. 42 patients with refractory angina at rest were treated with intra-aortic balloon pumping. Pain relief was prompt in 41 (98%), who subsequently underwent coronary artery bypass grafting. Total myocardial infarction rate was 11% (5/42), total mortality rate was 7%. Perioperative myocardial infarction rate was 8% (4/42) and perioperative mortality was 7% (3/42). Pain relief was prompt in 14/17 patients (82%) with post infarct refractory angina. In 3 patients pain persisted despite intra-aortic balloon pumping, all sustained a myocardial infarction, 1 died, 2 other patients were excluded for surgery. 12 patients underwent coronary artery bypass grafting, none died, none developed acute myocardial infarction, 3 have mild stable angina. In 8 patients a slowly evolving myocardial infarction was suspected. Pain relief was prompt in 7/8 (88%) after institution of intra-aortic balloon pumping. Intra-aortic balloon pumping improves prognosis in cardiogenic shock after myocardial infarction, and abolishes refractory ischemic pain.

Adult↗
PubMed1978

Computer analysis of oximetry data in cardiac catheterization.

An on-line computer technique is described for the detection and quantitation of left-to-right shunts. The computer used Student's t test to evaluate the probability that variations in right heart oxygen saturations were due to left-to-right shunts. The computer method was found to compare favorably to the present step-up method of detecting left-to-right shunts. The computer also calculated pulmonary blood flow, systemic blood flow, their ratio, and shunt blood flow as accurately as standard methods, as evidenced by correlation coefficients of 0.98, 0.94, 0.95, and 0.71 between the computer and hand calculations.

Cardiac Catheterization↗
PubMed1977

Effectiveness of intraaortic balloon pumping without cardiac surgery for patients with severe heart failure secondary to a recent myocardial infarction.

Twenty-five patients with class III or class IV left ventricular failure (Myocardial Infarction Research Unit criteria) after a recent myocardial infarction were treated with intraaortic balloon pumping between December 1, 1972 and December 1, 1976. Three patients had no improvement and died during pumping. Two patients with improvement died during at attempt at weaning from circulatory assistance. Of 20 patients successfully weaned, 6 died within 3 months, 5 of these within 10 days after the weaning procedure. Of 14 patients who survived for more than 3 months, 13 were alive on February 15, 1977. Twelve of these 13 were in functional class II and 6 had resumed professional activities. Intraaortic balloon pumping proved an effective method for treating severe left ventricular failure after an acute myocardial infarction. Even withour surgery, 14 of 25 patients survived 3 or more months after an acute infarction complicated by serious pump failure.

Adult↗
PubMed1977

Automatic data processing in the cardiac catheterization laboratory.

A review of automatic data processing in the cardiac catherization lab is presented. The emphasis placed on on-line manometry, indicator dilution and off-line quantitative ventriculography. The system organization is described and several specific examples given to illustrate the level of detail necessary to specify such a system. The clinical use of the system is described together with an evaluation of the original design goals in terms of the actual performance of the system. A few unexpected benefits have emerged with respect to quality control and reliability, but one of the original design goals, speeding up the catheterization procedure, has proven to be unrealistic. The next logical steps in the software and hardware evolution are described with the emphasis placed on making the system a more effective tool for the clinician.

Cardiac Catheterization↗
PubMed1977

Cardiovascular and antiarrhythmic effects of aprindine (AC1802) during partial occlusion of a coronary artery in the pig.

The effect of intravenously administered aprindine (AC1802) as a prophylactic agent against ventricular arrhythmias was studied in pigs. During the first 30 min of ischaemia 5 of the 22 untreated animals died because of ventricular fibrillation against 1 of the 23 animals pretreated with aprindine (P=0.09). Ventricular tachycardias were observed in 10 untreated animals and in none of the aprindine group (P=0.0002). The incidence of other arrhythmias was significantly less in the aprindine group compared with the untreated group (P less than 0.02).

Animals↗